SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ----------------------------------------------------------------- FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT: May 9, 1997 ----------------------------------------------------------------- ST. JUDE MEDICAL, INC. ---------------------- (Exact Name of Registrant) Minnesota 0-8672 41-1276891 - ------------------------ --------------------- ---------------- (State of Incorporation) (Commission File No.) (IRS Employer Identification Number) One Lillehei Plaza St. Paul, Minnesota 55117 ------------------------------------------- (Address of Principal Executive Offices) (612) 483-2000 ----------------------------------- (Registrant's telephone number) Item 5. Other Events. St. Jude Medical, Inc. announced on April 21, 1997 that the Hart-Scott-Rodino waiting period for the previously announced proposed merger of Ventritex, Inc. with and into St. Jude Medical's wholly-owned subsidiary Pacesetter, Inc. has been terminated. Closing of the transaction is subject, among other things, to approval of the related merger agreement by Ventritex stockholders at a special meeting scheduled for May 12, 1997. Item 7. Financial Statements, Pro Forma Financial Information and Exhibits. (c) Exhibits. Exhibit 1 -- Press Release issued on April 21, 1997 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: May 9, 1997 ST. JUDE MEDICAL, INC. By: /s/ Kevin T. O'Malley ----------------------------- Name: Kevin T. O'Malley Title: Vice President EXHIBIT INDEX Exhibit No. Description - ----------- ----------- 1 Press Release issued on April 21, 1997